about
Potential Anti-Atherosclerotic Properties of AstaxanthinSHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients.SHP-1 is a target of regorafenib in colorectal cancer.Erythroblast transformation by the friend spleen focus-forming virus is associated with a block in erythropoietin-induced STAT1 phosphorylation and DNA binding and correlates with high expression of the hematopoietic phosphatase SHP-1.Promoter-specific induction of the phosphatase SHP-1 by viral infection and cytokines in CNS gliaPharmacological Targeting SHP-1-STAT3 Signaling Is a Promising Therapeutic Approach for the Treatment of Colorectal Cancer.Regulation of miR-200c/141 expression by intergenic DNA-looping and transcriptional read-through.Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV-1-transformed T cells.Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotypeInterferon-beta treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1.SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma.Astaxanthin treatment reduced oxidative induced pro-inflammatory cytokines secretion in U937: SHP-1 as a novel biological target.Shp1 function in myeloid cells.PU.1 activates transcription of SHP-1 gene in hematopoietic cells.Tumoral prostate shows different expression pattern of somatostatin receptor 2 (SSTR2) and phosphotyrosine phosphatase SHP-1 (PTPN6) according to tumor progression.Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.
P2860
Q26767224-26BB67D7-CA17-4562-890C-925A68CF95D8Q33904273-1FBB2127-0CF4-4042-BFF4-1819945BC8C7Q34227671-B19523A3-34E9-4B8D-98E9-8EB2EB528265Q34651509-3127DD76-EB11-43DB-B3C4-202BB2E49260Q36174906-013F192A-9852-4660-89B5-529E417A5CA1Q36177646-AA731640-0A5A-44ED-A56F-70A1F6C873C7Q36503366-E0813C20-E2D6-404A-9EFB-CE0D41CEB128Q37062143-86F19421-5024-46BC-81BB-97E6452F1367Q37301528-1B56CD5A-85B1-4A9A-84EF-A2D103EBA241Q37348839-7BEC3661-0331-4752-A325-F3D277BA3EA4Q38916619-FF91CECD-9C36-43D6-8BF7-0F0A53B475A6Q39332621-AD1F6E53-E3B0-4373-8BB3-A60902C9CE92Q39367824-E41DCFAB-27C3-46D9-86E0-0CD0371A142DQ40184111-689CBF65-0E56-47BB-8C2E-451E1F0535FCQ41815304-B23F0497-562E-42E7-B033-4CFBD8D3801FQ42000292-3ADC23C6-EB48-4514-A835-D2BACFF18ABB
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Molecular mechanisms underlying SHP-1 gene expression.
@en
type
label
Molecular mechanisms underlying SHP-1 gene expression.
@en
prefLabel
Molecular mechanisms underlying SHP-1 gene expression.
@en
P2093
P2860
P1433
P1476
Molecular mechanisms underlying SHP-1 gene expression.
@en
P2093
Alberto Martin
Florence Wing Ling Tsui
Hing Wo Tsui
Kathleen Hasselblatt
Samuel Chi-ho Mok
P2860
P304
P356
10.1046/J.1432-1033.2002.02986.X
P407
P577
2002-06-01T00:00:00Z